LncRNA MIR600HG inhibits laryngeal cancer development by mediating the miR‐424‐5p/BTG2 axis

Abstract

AbstractLaryngeal carcinoma is the predominant kind of tumor seen under the category of head and neck malignancies. LncRNA MIR600HG affects tumor morphology in numerous cancer types. However, the function of MIR600HG in laryngeal cancer remains unclear. Protein and gene expressions were analyzed by using western blot and quantitative real time polymerase chain reaction. Cells proliferation and migration were evaluated by EdU and transwell assays. Flow cytometry was performed to detect cells apoptosis. The interaction between MIR600HG or B‐cell translocation gene 2 (BTG2) and miR‐424‐5p was analyzed by dual luciferase reporter assay and RNA immunoprecipitation. The expression of MIR600HG in laryngeal cancer tissues was lower than that in normal tissues, and low expression of MIR600HG was associated with poor prognosis in laryngeal cancer. Furthermore, overexpression of MIR600HG resulted in a reduction in cellular proliferation and the promotion of apoptosis in both HEp‐2 and Tu‐212. Mechanically, miR‐424‐5p was a direct target of MIR600HG, and overexpression of MIR600HG reduced miR‐424‐5p expression. Furthermore, BTG2 was a target gene of miR‐424‐5p and miR‐424‐5p upregulation suppressed the expression of BTG2. In addition, overexpression of BTG2 inhibited laryngeal cancer progression, whereas MIR600HG knockdown or miR‐424‐5p overexpression reversed the role of BTG2. This work suggested that MIR600HG represses laryngeal tumor development by regulating the miR‐424‐5p/BTG2 axis, which provides new molecules for early diagnosis of laryngeal cancer in the future.